Finance

Lists
Why is 688193 down 2,28%?
Dive Deeper
688193:SHA
Shanghai Rendu Biotechnology Co Ltd
CNÂ¥46,32
-2,28%
(-1,08) 1D
16 Okt., 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688193...
Open
CNÂ¥47,70
High
CNÂ¥48,50
Low
CNÂ¥45,83
Mkt. cap
1,99 mjd
Avg. vol.
478,86 k
Volume
551,35 k
Dividend
2,48%
Quarterly dividend
CNÂ¥0,29
Ex-dividend date
10 Jun. 2026
P/E ratio
95,56
52-wk high
CNÂ¥63,56
52-wk low
CNÂ¥40,00
EPS
CNÂ¥0,48
No. of employees
235
Open
CNÂ¥47,70
High
CNÂ¥48,50
Low
CNÂ¥45,83
Mkt. cap
1,99 mjd
Avg. vol.
478,86 k
Volume
551,35 k
Dividend
2,48%
Quarterly dividend
CNÂ¥0,29
Ex-dividend date
10 Jun. 2026
P/E ratio
95,56
52-wk high
CNÂ¥63,56
52-wk low
CNÂ¥40,00
EPS
CNÂ¥0,48
No. of employees
235
News stories
From web sources and news partners
About Shanghai Rendu Biotechnology Co Ltd
CEO-
Employees235
Founded13 Jun. 2007
Headquarters-
SectorMedical device
Websiterdbio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
37,91 m
42,79 m
42,08 m
37,36 m
Cost of goods sold
7,93 m
11,00 m
10,01 m
7,44 m
Cost of revenue
7,93 m
11,00 m
10,01 m
7,44 m
Research and development expenses
9,26 m
8,39 m
6,69 m
6,12 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24,41 m
30,59 m
22,68 m
25,63 m
Operating expense
23,43 m
34,70 m
29,53 m
31,79 m
Total operating expenses
31,36 m
45,70 m
39,54 m
39,24 m
Operating income
6,55 m
-2,91 m
2,54 m
-1,88 m
Other non operating income
35,50 k
-229,22 k
-49,46 k
50,36 k
EBT including unusual items
6,58 m
2,88 m
5,47 m
4,86 m
EBT excluding unusual items
8,38 m
722,99 k
5,91 m
3,23 m
Income tax expense
1,60 m
-196,52 k
474,90 k
276,18 k
Effective tax rate
24,35%
-6,83%
8,68%
5,69%
Other operating expenses
-2,78 m
765,60 k
-60,22 k
-18,26 k
Net income
4,98 m
3,07 m
5,00 m
4,58 m
Net profit margin
13,12%
7,18%
11,87%
12,26%
Earnings per share
-
-
-
-
Interest and investment income
1,84 m
4,01 m
3,47 m
5,20 m
Interest expense
-82,10 k
-42,18 k
-49,67 k
-55,07 k
Net interest expenses
1,76 m
3,96 m
3,42 m
5,15 m
Depreciation and amortization charges
-
-
-
-
EBITDA
10,08 m
457,33 k
5,91 m
1,42 m
Gain or loss from assets sale
7,32 k
386,31 k
-
-14,90 k
AI content may include mistakes. Learn more
Google-programme